新五豐(600975.SH)定增事項獲湖南省國資委批覆
格隆匯12月24日丨新五豐(600975.SH)公佈,2020年12月23日,公司接到了湖南省現代農業產業控股集團有限公司的通知,現代農業集團收到湖南省國資委《湖南省國資委關於湖南新五豐股份有限公司非公開發行股票有關事項的批覆》,原則同意湖南新五豐股份有限公司本次非公開發行股票方案,即:發行數量不超過1.51億股(含)股票,發行價格為6.81元/股,募集資金總額不超過10.2999億元(含),其中:湖南省現代農業產業控股集團有限公司認購5億元、湖南省糧油食品進出口集團有限公司認購2999.00萬元、湖南興湘投資控股集團有限公司認購3億元、湖南建工集團有限公司認購2億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.